Category: New products
-
More D.C. Notable Photos Available at Alamy
Technology News and Literature, publisher of Science & Enterprise, offers new photos of leading figures in today’s Washington, D.C. through the Alamy photo agency.
-
Nanotech Pancreatic Cancer Immunotherapy Gains FDA Fast Track
The developer of an experimental immunotherapy delivering nanoscale payloads to treat pancreatic cancer says the treatment received fast-track status from the Food and Drug Administration.
-
Trial Okayed for Gene-Edited Stem Cell Lupus Treatment
A developer of treatments for cancer and autoimmune disorders from stem cells says FDA cleared its request to start a clinical trial of its therapy for systemic lupus erythematosus.
-
DNA Data Company Creates Portable Storage Media
A company developing DNA into a feasible method for large-scale data storage unveiled a credit card-sized device using DNA for off-line data storage.
-
Partnership to Discover Mental Health Peptides in Milk
A collaboration between biotechnology and dairy products businesses seeks to identify peptides in milk to form into dietary supplements for people with mood disorders.
-
Study to Provide Real World Data for A.I. Seizure Forecasts
A developer of medical monitoring systems with data from wearable devices will soon start asking individuals with epilepsy to offer data for an algorithm that predicts seizures.
-
Trial Set to Test Inhaled mRNA for Viral Infections
A developer of messenger RNA therapies for respiratory and rare diseases says it received clearance to begin a clinical trial in the U.K. for an inhaled treatment for viral lung conditions.
-
Vaccine Patch Shown Safe, Produces Measles/Rubella Antibodies
A vaccine delivered with a patch device is shown in a clinical trial to generate neutralizing antibodies against measles and rubella similar to conventional injections.
-
Academic, Industry Labs to Build Brain Cell Models
Researchers from university labs in the U.K. are developing models of brain cell interactions using a company’s synthetic human cells derived from stem cells.
-
Lab-Grown Tissue Company Gains $38M in Seed Funds
A company producing tissue samples in the lab, for drug discovery and preclinical research with robotics and artificial intelligence, raised $38 million in seed funding.